Enter
Enter is a Brazilian AI platform that runs high-volume litigation for corporate legal departments.
Litegy AI
Litegy AI develops software that reviews medical records to surface litigation-relevant medical issues, causation questions, and expert specialty considerations for legal and insurance teams.
Enter vs Litegy AI
At a Glance
| Detail | Enter | Litegy AI |
|---|---|---|
| Category | eDiscovery | eDiscovery |
| Total raised | $135M | Not disclosed |
| Rounds tracked | 2 | Not disclosed |
| Latest round | Series B, $100M · May 2026 | Not disclosed |
| Last valuation | $1.2B | Not disclosed |
| Lead investors | Founders Fund, Sequoia Capital | Not disclosed |
| Built for | In-house teams | Not disclosed |
| Headquarters | Brazil | US |
Funding, Side by Side
Enter rounds
- May 2026Series B$100M
- Sep 2025Series A$35M
Litegy AI rounds
No public rounds tracked yet.
Our Take
We have not tested these two head to head yet. The numbers above come from public funding announcements. If you use either one, tell us what you found and it may become a Field Note.
Quick Answers
- Which has raised more, Enter or Litegy AI?
- Enter has raised $135M in disclosed funding, compared with no disclosed amount for Litegy AI.
- What is Enter best for?
- Enter is a Brazilian AI platform that runs high-volume litigation for corporate legal departments.
- What is Litegy AI best for?
- Litegy AI develops software that reviews medical records to surface litigation-relevant medical issues, causation questions, and expert specialty considerations for legal and insurance teams.
Source: Legal Tech Circle funding data, from public announcements. Updated November 11, 2026.